n-3 polyunsaturated fatty acids supplementation decreases asymmetric dimethyl arginine and arachidonate accumulation in aging spontaneously hypertensive rats

European Journal of Nutrition

Volumn 44, Issue 6, 2005, Pages 327-333

  Raimondi, Laura ^a,b   Lodovici, Maura ^a   Visioli, Francesco ^c   Sartiani, Laura ^a   Cioni, Laura ^a   Alfarano, Chiara ^a   Banchelli, Grazia ^a   Pirisino, Renato ^a   Cecchi, Enrica ^a   Cerbai, Elisabetta ^a   Mugelli, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Sciences University of Milan ^*  (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

ADMA; Cardiovascular risk; Hypertension; Long chain fatty acids

Indexed keywords

ARACHIDONIC ACID; DIMETHYLARGININASE; DOCOSAHEXAENOIC ACID; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; N(G),N(G) DIMETHYLARGININE; NITRITE; OLIVE OIL; OMEGA 3 FATTY ACID;

AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOASSAY; KIDNEY; LIPID COMPOSITION; MALE; METABOLISM; NONHUMAN; POLARIZATION IMMUNOASSAY; RAT; RAT STRAIN; SPECTROPHOTOMETRY; SUPPLEMENTATION;

AGING; ANIMALS; ARACHIDONIC ACID; ARGININE; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; MALE; RATS; RATS, INBRED SHR; RISK FACTORS;

ANIMALIA;

EID: 24644464695     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-004-0528-5     Document Type: Article

References (35)

1. Bucher HC, Hengstler P, Schindler C, Meier G (2002) N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 112:298-304
2. Kris-Etherton PM, Harris WS, Appel LJ (2003) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23:20-30
3. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC (1995) Dietary Intake of Marine n-3 Fatty Acids, Fish Intake, and the Risk of Coronary Disease among Men. N Engl J Med 332:977-983
4. Singh RB (1999) GISSI-Prevenzione trial. Lancet 354:1556-1557
5. (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. The Lancet 354:447-455
6. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F, on behalf of the GISSI-Prevenzione Investigators (2002) Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105:1897
7. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, St Jeor S, Suttie J, Tribble DL, Bazzarre TL (2000) AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke 31:2751-2766
8. Christon RA (2003) Mechanisms of action of dietary fatty acids in regulating the activation of vascular endothelial cells during atherogenesis. Nutr Rev 61:272-279
9. Leaf A, Kang JX, Xiao YF, Billman GE (2003) Clinical Prevention of Sudden Cardiac Death by n-3 Polyunsaturated Fatty Acids and Mechanism of Prevention of Arrhythmias by n-3 Fish Oils. Circulation 107:2646-2652
10. Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842-1847
11. Boger RH (2003) The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59:824-833
12. Delles C, Schneider MP, John S, Gekle M, Schmieder RE (2002) Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension. Am J Hypertens 15:590-593
13. Asagami T, Abbasi F, Stuelinger M, Lamendola C, McLaughlin T, Cooke JP, Reaven GM, Tsao PS (2002) Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes. Metabolism 51:843-846
14. Cerbai E, De Paoli P, Sartiani L, Lonardo G, Mugelli A (2003) Treatment with irbesartan counteracts the functional remodeling of ventricular myocytes from hypertensive rats. J Cardiovasc Pharmacol 41:804-812
15. Pettersson A, Uggla L, Backman V (1997) Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 692:257-262
16. Leiper JM, Santa MJ, Chubb A, MacAllister RJ, Charles IG, Whitley GS, Vallance P (1999) Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 343(Pt 1):209-214
17. Achan V, Broadhead M, Malaki M, Whitley GS, Leiper J, MacAllister R, Vallance P (2003) Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23:1455-1459
18. Ogawa T, Kimoto M, Sasaoka K (1987) Occurrence of a new enzyme catalyzing the direct conversion of NG,NG-dimethyl-L-arginine to L-citrulline in rats. Biochem Biophys Res Commun 148:671-677
19. Espey MG, Miranda KM, Pluta RM, Wink DA (2000) Nitrosative Capacity of Macrophages Is Dependent on Nitricoxide Synthase Induction Signals. J Biol Chem 275:11341-11347
20. Brunelli T, Pepe G, Marcucci R, Giusti B, Prisco D, Abbate R, Fedi S (2001) Comparison of three methods for total homocysteine plasma determination. Clin Lab 47:393-397
21. Visioli F, Rihn LL, Rodriguez de Turco EB, Kreisman NR, Bazan NG (1993) Free fatty acid and diacylglycerol accumulation in the rat brain during recurrent seizures is related to cortical oxygenation. J Neurochem 61:1835-1842
22. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509
23. Kumar U, Shin Y, Wersinger C, Patel Y, Sidhu A (2003) Diminished expression of constitutive nitric oxide synthases in the kidney of spontaneously hypertensive rat. Clin Exp Hypertens 25:271-282
24. Delachambre MC, Narce M, Asdrubal P, Poisson JP (1998) Changes in tissue polyunsaturated fatty acids with age, in spontaneously hypertensive rats. Lipids 33:795-801
25. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP (1999) Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99:3092-3095
26. Davis MR, Ortegon DP, Kerby JD, Ignarro LJ, Kashyap VS (2003) Endothelial dysfunction after arterial thrombosis is ameliorated by L-arginine in combination with thrombolysis. J Vasc Interv Radiol 14:233-239
27. Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS (2002) Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 90:974-982
28. Bexis S, Lungershausen YK, Mano MT, Howe PR, Kong JQ, Birkle DL, Taylor DA, Head RJ (1994) Dietary fish oil administration retards blood pressure development and influences vascular properties in the spontaneously hypertensive rat (SHR) but not in the stroke prone-spontaneously hypertensive rat (SHR-SP). Blood Press 3:120-126
29. Trippodo NC, Frohlich ED (1981) Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res 48:309-319
30. Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K (2000) Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 16:861-865
31. Sperling RI (1991) Dietary omega-3 fatty acids: effects on lipid mediators of inflammation and rheumatoid arthritis. Rheum Dis Clin North Am 17:373-389
32. Sattar N (2004) Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease? Clin Sci (Lond)
33. Eid HM, Eritsland J, Larsen J, Arnesen H, Seljeflot I (2003) Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin. Atherosclerosis 166:279-284
34. Holm T, Aukrust P, Aagaard E, Ueland T, Haugstad TS, Kjekshus J, Simonsen S, Froland SS, Gullestad L, Andreassen AK (2002) Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension. Transplantation 74:1395-1400
35. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M (2004) Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350:4-7